← All trials
NCT04349696
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 11, 2014
- Primary completion
- Apr 30, 2018
- Completion date
- Apr 30, 2018
- First posted
- Apr 16, 2020
- Last posted
- Apr 16, 2020
- Enrollment
- 16
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Orient Europharma Co., Ltd.Lead sponsor
- Chang Gung UniversityOverall official - principal investigator
- Taipei Veteran General hospitalOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.